These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 28252047)

  • 21. Constitutive expression of pentraxin 3 (PTX3) protein by human amniotic membrane cells leads to formation of the heavy chain (HC)-hyaluronan (HA)-PTX3 complex.
    Zhang S; Zhu YT; Chen SY; He H; Tseng SC
    J Biol Chem; 2014 May; 289(19):13531-42. PubMed ID: 24652286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of macrophage migration inhibitory factor (MIF) in the effects of oxidative stress on human retinal pigment epithelial cells.
    Ko JA; Sotani Y; Ibrahim DG; Kiuchi Y
    Cell Biochem Funct; 2017 Oct; 35(7):426-432. PubMed ID: 28906008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells.
    Xiao W; Chen X; Liu X; Luo L; Ye S; Liu Y
    J Cell Mol Med; 2014 Apr; 18(4):646-55. PubMed ID: 24456602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteotoxic Stress Desensitizes TGF-beta Signaling Through Receptor Downregulation in Retinal Pigment Epithelial Cells.
    Tan X; Chen C; Zhu Y; Deng J; Qiu X; Huang S; Shang F; Cheng B; Liu Y
    Curr Mol Med; 2017; 17(3):189-199. PubMed ID: 28625142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of gremlin, a BMP antagonist, and epithelial-to-mesenchymal transition in proliferative vitreoretinopathy.
    Lee H; O'Meara SJ; O'Brien C; Kane R
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4291-9. PubMed ID: 17724219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory Effect of Bone Morphogenetic Protein 4 in Retinal Pigment Epithelial-Mesenchymal Transition.
    Yao H; Li H; Yang S; Li M; Zhao C; Zhang J; Xu G; Wang F
    Sci Rep; 2016 Sep; 6():32182. PubMed ID: 27586653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.
    Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F
    FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quercetin inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in human retinal pigment epithelial cells via the Smad pathway.
    Cai W; Yu D; Fan J; Liang X; Jin H; Liu C; Zhu M; Shen T; Zhang R; Hu W; Wei Q; Yu J
    Drug Des Devel Ther; 2018; 12():4149-4161. PubMed ID: 30584279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of retinal pigment epithelial cell β-catenin signaling in experimental proliferative vitreoretinopathy.
    Umazume K; Tsukahara R; Liu L; Fernandez de Castro JP; McDonald K; Kaplan HJ; Tamiya S
    Am J Pathol; 2014 May; 184(5):1419-28. PubMed ID: 24656918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eupatilin attenuates TGF-β2-induced proliferation and epithelial-mesenchymal transition of retinal pigment epithelial cells.
    Cinar AK; Ozal SA; Serttas R; Erdogan S
    Cutan Ocul Toxicol; 2021 Jun; 40(2):103-114. PubMed ID: 33719768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of Na,K-ATPase β1-subunit in TGF-β2-mediated epithelial-to-mesenchymal transition in human retinal pigmented epithelial cells.
    Mony S; Lee SJ; Harper JF; Barwe SP; Langhans SA
    Exp Eye Res; 2013 Oct; 115():113-22. PubMed ID: 23810808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial-mesenchymal transition suppresses ERas to activate autophagy in retinal pigment epithelial cells in proliferative vitreoretinopathy.
    Pan J; Zhao LX
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4627-4634. PubMed ID: 32432726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin induces epithelial-mesenchymal transition and collagen production by retinal pigment epithelial cells via autocrine PDGF-receptor signaling.
    Bastiaans J; van Meurs JC; van Holten-Neelen C; Nagtzaam NM; van Hagen PM; Chambers RC; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8306-14. PubMed ID: 24302586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HC-HA/PTX3 Purified From Human Amniotic Membrane Reverts Human Corneal Fibroblasts and Myofibroblasts to Keratocytes by Activating BMP Signaling.
    Zhu YT; Li F; Zhang Y; Chen SY; Tighe S; Lin SY; Tseng SCG
    Invest Ophthalmol Vis Sci; 2020 May; 61(5):62. PubMed ID: 32462202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectively Intervening Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells With a Combination of ROCK and TGF-β Signaling Inhibitors.
    Chen Y; Wu B; He JF; Chen J; Kang ZW; Liu D; Luo J; Fang K; Leng X; Tian H; Xu J; Jin C; Zhang J; Wang J; Zhang J; Ou Q; Lu L; Gao F; Xu GT
    Invest Ophthalmol Vis Sci; 2021 Apr; 62(4):21. PubMed ID: 33861322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Merlin Regulates Epithelial-to-Mesenchymal Transition of ARPE-19 Cells via TAK1-p38MAPK-Mediated Activation.
    Takahashi E; Haga A; Tanihara H
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2449-58. PubMed ID: 25783601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1/STAT3 signaling pathway.
    Chen X; Yang W; Deng X; Ye S; Xiao W
    Mol Vis; 2020; 26():517-529. PubMed ID: 32818015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/β-catenin pathway.
    Ma X; Long C; Wang F; Lou B; Yuan M; Duan F; Yang Y; Li J; Qian X; Zeng J; Lin S; Shen H; Lin X
    J Cell Mol Med; 2021 May; 25(9):4220-4234. PubMed ID: 33759344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo downregulation of innate and adaptive immune responses in corneal allograft rejection by HC-HA/PTX3 complex purified from amniotic membrane.
    He H; Tan Y; Duffort S; Perez VL; Tseng SC
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1647-56. PubMed ID: 24519420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bortezomib inhibits proliferation, migration, and TGF-β1-induced epithelial-mesenchymal transition of RPE cells.
    Moon K; Lee HG; Baek WK; Lee Y; Kim KS; Jun JH; Kim JY; Joo CK
    Mol Vis; 2017; 23():1029-1038. PubMed ID: 29386876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.